클린(CLNN)는 NASDAQ에 상장된 Consumer Defensive · Packaged Foods 기업입니다. 현재가 $4.14 (-1.19%), 시가총액 $0.09B, 52주 범위 $2.37 ~ $12.50.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic
클린의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
클린의 현재 주가는 $4.14 (-1.19%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
클린의 시가총액은 약 $0.09B입니다.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug can